A single-blind, randomised, placebo-controlled, comparative induced pain model to investigate topical ibuprofen (TIB200) in healthy volunteers

Trial Profile

A single-blind, randomised, placebo-controlled, comparative induced pain model to investigate topical ibuprofen (TIB200) in healthy volunteers

Planning
Phase of Trial: Phase I

Latest Information Update: 17 Nov 2014

At a glance

  • Drugs Ibuprofen (Primary)
  • Indications Pain
  • Focus Adverse reactions
  • Most Recent Events

    • 17 Nov 2014 New trial record
    • 11 Sep 2014 According to a Futura Medical media release, headline results from this trial are expected during the first half of 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top